drugset / Trial / NCT03673618

Soluble Corn Fiber Supplementation for Asthma

NCT03673618

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Studies of the importance of the human microbiome have demonstrated that microbial metabolites of fermentation of our dietary products (e.g. dietary fiber) have a multitude of health benefits. The investigators aim to determine whether supplementation of asthmatic children with soluble corn fiber alongside standard of care reduces airway inflammation driven by the gut microbial metabolites acetate, propionate, or butyrate (short chain fatty acids).

Timeline

Start
2019-09-01
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Soluble Corn Fiber Unknown 12 g